The Turkish journal of pediatrics · 2006
Autoimmune hemolytic anemia as presenting manifestation of primary splenic anaplastic large cell lymphoma.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Köksal Yavuz, Calişkan Umran, Uçar Canan, Erekul Selim, Ilerisoy Yakut Zeynep
Аннотация
Autoimmune hemolytic anemia (AIHA) is an unusual complication of malignancy. We diagnosed primary splenic anaplastic large cell lymphoma (ALCL) in a patient. A seven-year-old boy presented with Coombs test-positive hemolytic anemia. After a course of prednisolone therapy, a complete response for anemia was achieved. Twenty months later, in addition to severe hemolytic anemia, the patient was diagnosed with ALCL after splenectomy and pathologic examination of the sample. The recognition of this clinical picture as a complication of non-Hodgkin's lymphoma has important implications. The most effective management of AIHA in the setting of cancer is to treat the underlying malignancy.
Предметные рубрики MeSH
Anemia, Hemolytic, AutoimmuneAnti-Inflammatory AgentsAntineoplastic Combined Chemotherapy ProtocolsChildCyclophosphamideDaunorubicinDisease-Free SurvivalFollow-Up StudiesGlucocorticoidsHumansImmunohistochemistryLymphoma, Large B-Cell, DiffuseMaleMethotrexateMethylprednisoloneNeoplasm StagingPrednisoneSpleenSplenectomySplenic NeoplasmsSplenomegalyTime FactorsVincristine